Scarica l'app Stockscreener
107.00
0.36%
0.38
Dopo l'orario di chiusura:
106.05
-0.95
-0.89%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Insmed Inc Borsa (INSM) Ultime notizie
Here’s Why TimesSquare Mid Cap Growth Strategy Added Insmed (INSM) - Yahoo Finance
Analysts Expect Breakeven For Insmed Incorporated (NASDAQ:INSM) Before Long - Moomoo
INSMInsmed Inc Options - Finviz
Insmed’s New Lung Disease Study Data A Win For Company, Says Analyst - Stocktwits
Insmed Incorporated(NasdaqGS: INSM) dropped from Russell 2500 Growth Benchmark - marketscreener.com
INSM, FSLR, APTV: Dreaded Death Cross Has Formed On These Stocks — What It Means For Investors - Stocktwits
Insmed Incorporated(NasdaqGS:INSM) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Insmed Incorporated(NasdaqGS: INSM) dropped from Russell 3000 Value Benchmark - marketscreener.com
Insmed Incorporated(NasdaqGS: INSM) dropped from Russell Midcap Value Benchmark - marketscreener.com
Mizuho Maintains an Outperform Rating on Insmed Incorporated (INSM) - Yahoo Finance
INSM Stock Dips In Extended Trading After Experimental Skin Disease Drug Fails In Study - Stocktwits
Insmed Inc (INSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Insmed Insider Sold Shares Worth $2,210,763, According to a Recent SEC Filing - marketscreener.com
INSMED (INSM) CEO Lewis exercises options and sells 21,398 shares under 10b5-1 plan - Stock Titan
Price to earnings forward of Insmed Incorporated – NASDAQ:INSM - TradingView
Form 144 INSMED INC For: 25 June - Investing.com UK
Form 144 INSMED INC For: 25 June By Investing.com - Investing.com Nigeria
Insmed Incorporated Actuals & Estimates (NASDAQ:INSM) - TradingView
Insmed Incorporated Actuals & Estimates (BX:IM8N) - TradingView
William Lewis files Form 144 — Insmed (NASDAQ: INSM) reports recent share dispositions - Stock Titan
Insmed | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Enterprise value to EBITDA forward of Insmed Incorporated – NASDAQ:INSM - TradingView
Enterprise value to EBIT forward of Insmed Incorporated – SWB:IM8N - TradingView
Price to book forward of Insmed Incorporated – SWB:IM8N - TradingView
Enterprise value to revenue forward of Insmed Incorporated – SWB:IM8N - TradingView
IM8N Forecast — Price Target — Prediction for 2027 - TradingView
Insmed names Butera SVP, general manager, global respiratory - ROI-NJ
Enterprise value to EBITDA forward of Insmed Incorporated – SWB:IM8N - TradingView
Non-Cystic Fibrosis Bronchiectasis Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Insmed Inc, AstraZeneca, Zambon, CSL Behring, Chiesi Farmace - Barchart.com
EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in Bronchiectasis - Yahoo Finance
Form 4 Insmed Inc For: 24 June By Investing.com - Investing.com Australia
Insmed chief legal officer Michael Smith sells $173,050 in stock By Investing.com - Investing.com South Africa
Insmed chief legal officer Michael Smith sells $173,050 in stock - Investing.com
Insider Sell Alert: Michael Smith Sells Shares of Insmed Inc (IN - GuruFocus
Insmed (NASDAQ: INSM) awards RSUs and stock options to SVP - Stock Titan
Insmed (INSM) SVP Samuele Butera files Form 3 showing no trades - Stock Titan
INSMED Inc (NASDAQ: INSM) CLO sells 1,806 shares under 10b5-1 plan - Stock Titan
Insmed Incorporated Announces Appointment of Samuele Butera as Senior Vice President, Global Respiratory and Member of Executive Committee, Effective June 23, 2026 - marketscreener.com
Press Release: Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory - Moomoo
Form 144 INSMED INC For: 22 June By Investing.com - Investing.com Australia
INSM Maintained by Evercore ISI Group -- Price Target Lowered to $160 - GuruFocus
Insmed taps Johnson & Johnson veteran to lead its respiratory push - Stock Titan
Form 144 INSMED INC For: 22 June - Investing.com UK
Should Insmed’s (INSM) NASDAQ-100 Exit and TPIP Focus Require Action From Investors? - Yahoo Finance
Michael Smith files Form 144 listing multiple INSM share sales (INSM) - Stock Titan
Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise? - Yahoo Finance
What's Driving Insmed's Recent Volatility - Kavout | AI
3 US Pharmaceutical Stocks With Cash Flow And Pricing Risk - Sahm
Insmed Stockanalyst coverage and sector comparison at week’s end - Ad-hoc-news.de
Insmed Inc (MIL:1INSM) Stock Price, Trades & News - GuruFocus
InvestingPro’s Fair Value spotted Insmed’s 44% drop before it happened By Investing.com - Investing.com
Insmed Incorporated(NasdaqGS: INSM) dropped from NASDAQ-100 Index - marketscreener.com
0.93%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):